SIGA Technologies Inc (SIGA)
6.52
+0.25
(+3.99%)
USD |
NASDAQ |
Nov 22, 16:00
6.52
0.00 (0.00%)
After-Hours: 16:11
SIGA Technologies Enterprise Value: 348.44M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 348.44M |
| November 20, 2024 | 347.01M |
| November 19, 2024 | 347.72M |
| November 18, 2024 | 342.01M |
| November 15, 2024 | 324.87M |
| November 14, 2024 | 350.58M |
| November 13, 2024 | 372.72M |
| November 12, 2024 | 404.85M |
| November 11, 2024 | 439.12M |
| November 08, 2024 | 441.26M |
| November 07, 2024 | 445.55M |
| November 06, 2024 | 451.97M |
| November 05, 2024 | 417.70M |
| November 04, 2024 | 400.56M |
| November 01, 2024 | 415.56M |
| October 31, 2024 | 416.27M |
| October 30, 2024 | 406.28M |
| October 29, 2024 | 408.42M |
| October 28, 2024 | 401.99M |
| October 25, 2024 | 384.14M |
| October 24, 2024 | 371.05M |
| October 23, 2024 | 372.48M |
| October 22, 2024 | 375.34M |
| October 21, 2024 | 391.75M |
| October 18, 2024 | 394.61M |
| Date | Value |
|---|---|
| October 17, 2024 | 405.31M |
| October 16, 2024 | 386.04M |
| October 15, 2024 | 381.76M |
| October 14, 2024 | 382.47M |
| October 11, 2024 | 391.04M |
| October 10, 2024 | 371.77M |
| October 09, 2024 | 367.49M |
| October 08, 2024 | 376.76M |
| October 07, 2024 | 391.75M |
| October 04, 2024 | 398.89M |
| October 03, 2024 | 397.46M |
| October 02, 2024 | 394.61M |
| October 01, 2024 | 398.17M |
| September 30, 2024 | 382.47M |
| September 27, 2024 | 389.78M |
| September 26, 2024 | 388.35M |
| September 25, 2024 | 374.79M |
| September 24, 2024 | 464.72M |
| September 23, 2024 | 494.69M |
| September 20, 2024 | 494.69M |
| September 19, 2024 | 501.83M |
| September 18, 2024 | 461.86M |
| September 17, 2024 | 455.44M |
| September 16, 2024 | 463.29M |
| September 13, 2024 | 456.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
170.48M
Minimum
Feb 05 2024
1.795B
Maximum
Aug 15 2022
437.97M
Average
406.48M
Median
Jun 03 2020
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.022B |
| Geovax Labs Inc | 16.88M |
| Abbott Laboratories | 210.81B |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| Chimerix Inc | -54.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.344M |
| Revenue (Quarterly) | 10.01M |
| Total Expenses (Quarterly) | 9.468M |
| EPS Diluted (Quarterly) | 0.02 |
| Gross Profit Margin (Quarterly) | 53.59% |
| Profit Margin (Quarterly) | 13.43% |
| Earnings Yield | 18.40% |
| Operating Earnings Yield | 22.32% |
| Normalized Earnings Yield | 18.40 |